Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Group 3 Pulmonary Hypertension
-
Respiratory Disorder -
Idiopathic Pulmonary Fibrosis (IPF)
- Results
-
Download -
Study results
LPS MA29957 Final Results August 2020 Belgium French
(PDF, 0.5 MB)
LPS MA29957 Final Results August 2020 Belgium Dutch
(PDF, 0.6 MB)
LPS MA29957 Final Results August 2020 English
(PDF, 1.9 MB)
LPS MA29957 Final Results August 2020 Egypt Arabic
(PDF, 0.7 MB)
LPS MA29957 Final Results August 2020 Greek
(PDF, 0.4 MB)
LPS MA29957 Final Results November 2020 Israel Arabic
(PDF, 0.8 MB)
LPS MA29957 Final Results November 2020 Israel Hebrew
(PDF, 3.1 MB)
LPS MA29957 Final Results November 2020 Israel Russian
(PDF, 0.4 MB)
LPS MA29957 Final Results October 2020 Netherlands Dutch.pdf
(PDF, 1.0 MB)
LPS MA29957 Final Results August 2020 Canada French
(PDF, 1.7 MB)
LPS MA29957 Final Results November 2020 Czech
(PDF, 2.0 MB)
LPS MA29957 Final Results October 2020 German
(PDF, 0.8 MB)
LPS MA29957 Final Results September 2020 Hungarian
(PDF, 1.0 MB)
LPS MA29957 Final Results August 2020 Italian
(PDF, 1.1 MB)
LPS MA29957 Final Results August 2020 Spanish
(PDF, 0.5 MB)
LPS MA29957 Final Results November 2020 Turkish.pdf
(PDF, 1.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com